Exchange: NASDAQ·Updated 04:25 PM EST
OBIO logo

OBIO Orchestra BioMed Holdings Inc

$6.52
$0.42
(6.00%)
Today
Closed $6.58
$0.06
(0.91%)
After Hours
Reported EarningsNov 10
Mkt Cap$550.93M
Vol554,267.00

About OBIO

Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded by David P. Hochman on May 25, 2020 and is headquartered in New Hope, PA.
54

Neutral Sentiment

How do you feel about OBIO?

Rayvio_News_Filter
$OBIO 🏥 Orchestra BioMed Holdings, Inc. completed enrollment in the BACKBEAT global pivotal trial of AVIM Therapy, randomizing 349 patients and exceeding the enrollment target. Actionable market event
2
BiotechSwings
Friday didn't whisper on $OBIO closed at 7.25, up 17.89% off a 6.15 close, tagged 7.37 and held most of it into the bell BTIG moved its target to 12 from 10 and kept Buy after the research day in New York, HC Wainwright went to 12 the same day two raises in one day on a name already up 29% in five sessions imo. BackBeat in hypertension and Virtue in artery disease are what's underneath it, and the desk and the price action are finally telling the same story
1
shoc24
$OBIO is ranked #24 in healthcare technical trend with a score of 81. I used Stock Meadow's scoring model. Build your own model and backtest it if you don't agree with mine.
AlertsAndNews
$OBIO Orchestra BioMed Announces Pricing of Public Offering "announced today the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $5.00 per share (the "Offering")."

Advertisement|Remove ads.